Multivitamin Recall Update for 25 States As FDA Sets Risk Level
A chewable multivitamin distributed across 25 states has been recalled after federal inspectors found the product contained lower‑than‑intended…
FDA under scrutiny: 4 issues facing beleaguered agency
The U.S. Food and Drug Administration (FDA) has faced an unusual convergence of political, scientific, legal and operational…
FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug…
Top FDA drug official is trying to hire a friend who’s seeking a bold new warning on antidepressants
WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
FDA Vaccine Chief Vinay Prasad Set to Leave Post Next Month
(Bloomberg) — The head of the US Food and Drug Administration’s division of vaccines and gene therapies is…
FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
Explainer | How TCM’s ‘miracle pill’ is used to treat strokes, but experts urge caution
This series is based on our reporting on TCM: its history, treatments and growing acceptance around the world.…
FDA to offer bonus payments to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…